Alembic Pharma undervalued
Buy Alembic Pharma
Current Market Price 778
Buy above 800 Closing basis
SL 720
Target 1120
Risk Reward Ratio = 1:4
Fundamental Snippets:
Market Cap - ₹ 15,298 Cr.
Current Price - ₹ 778
High / Low - ₹ 1,150 / 720
Stock P/E - 14.7
Book Value - ₹ 261
Dividend Yield - 1.80 %
ROCE - 26.0 %
ROE - 28.2 %
EPS - ₹ 53.0
EPS preceding year - ₹ 44.0
Face Value - ₹ 2.00
Debt to equity - 0.10
Price to book value - 2.98
PEG Ratio - 1.42
Promoter holding - 69.5 %
Change in Prom Hold - 0.00 %
Working capital - ₹ 1,410 Cr.
WC Days - 88.3
EVEBITDA - 11.2
Inven TO - 1.03
Current ratio - 2.44
Quick ratio - 0.92
CWIP - ₹ 2,182 Cr.
CMP / FCF - 80.8
Enterprise Value - ₹ 15,691 Cr.
Current Market Price 778
Buy above 800 Closing basis
SL 720
Target 1120
Risk Reward Ratio = 1:4
Fundamental Snippets:
Market Cap - ₹ 15,298 Cr.
Current Price - ₹ 778
High / Low - ₹ 1,150 / 720
Stock P/E - 14.7
Book Value - ₹ 261
Dividend Yield - 1.80 %
ROCE - 26.0 %
ROE - 28.2 %
EPS - ₹ 53.0
EPS preceding year - ₹ 44.0
Face Value - ₹ 2.00
Debt to equity - 0.10
Price to book value - 2.98
PEG Ratio - 1.42
Promoter holding - 69.5 %
Change in Prom Hold - 0.00 %
Working capital - ₹ 1,410 Cr.
WC Days - 88.3
EVEBITDA - 11.2
Inven TO - 1.03
Current ratio - 2.44
Quick ratio - 0.92
CWIP - ₹ 2,182 Cr.
CMP / FCF - 80.8
Enterprise Value - ₹ 15,691 Cr.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.